SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-039439
Filing Date
2023-08-08
Accepted
2023-08-08 10:01:26
Documents
94
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mcrb-20230630.htm   iXBRL 10-Q 3886533
2 EX-31.1 mcrb-ex31_1.htm EX-31.1 17171
3 EX-31.2 mcrb-ex31_2.htm EX-31.2 17031
4 EX-32.1 mcrb-ex32_1.htm EX-32.1 10660
5 EX-32.2 mcrb-ex32_2.htm EX-32.2 10601
  Complete submission text file 0000950170-23-039439.txt   13673930

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mcrb-20230630_def.xml EX-101.DEF 317266
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mcrb-20230630.xsd EX-101.SCH 88012
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mcrb-20230630_pre.xml EX-101.PRE 513815
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mcrb-20230630_lab.xml EX-101.LAB 637931
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mcrb-20230630_cal.xml EX-101.CAL 64936
88 EXTRACTED XBRL INSTANCE DOCUMENT mcrb-20230630_htm.xml XML 2596593
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37465 | Film No.: 231149678
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences